CEBP Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

Published online first on January 9, 2008
[Cancer Epidemiology Biomarkers & Prevention, 10.1158/1055-9965.EPI-07-0517]
This Article
Right arrow Full Text (Online First [PDF])
Right arrow All Versions of this Article:
1055-9965.EPI-07-0517v1
17/1/148    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Van Dyke, A. L.
Right arrow Articles by Schwartz, A. G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Dyke, A. L.
Right arrow Articles by Schwartz, A. G.

Research Articles

Regular Adult Aspirin Use Decreases the Risk of Non-Small Cell Lung Cancer among Women

Alison L. Van Dyke 1*, Michele L. Cote , Geoffrey Prysak , Gina B. Claeys , Angie S. Wenzlaff , Ann G. Schwartz

1 1Cancer Biology Program, 2Population Studies and Prevention Program, Karmanos Cancer Institute, and 3Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan

* To whom correspondence should be addressed. E-mail: avandyk{at}med.wayne.edu.


   Abstract

Background: Prior studies indicate that use of aspirin or other nonsteroidal anti-inflammatory drugs (NSAID) is associated with a decreased risk of non-small cell lung cancer (NSCLC); however, results have been contradictory in part because of variation in study design. Few studies have examined the use of aspirin or other NSAIDs on risk of NSCLC in women.

Methods: Through a case-control study of African American and Caucasian women with and without NSCLC, we examined the relationship between use of aspirin, NSAIDs, and acetaminophen and risk of NSCLC. Risk was estimated by calculating odds ratios and 95% confidence intervals for ever/never use, duration of use, and duration of use category (never, 1-5 years, >5 years) after adjusting for major risk factors for lung cancer. Risk estimates were stratified by race, age, smoking history, and body mass index.

Results: Ever use of adult-strength aspirin was associated with a significant reduction in risk of NSCLC (odds ratio, 0.66; 95% confidence interval, 0.46-0.94). Additionally, there was a significant trend toward a reduced risk of NSCLC in adult-strength aspirin users with increasing duration of use (Ptrend = 0.02). In stratified analyses, aspirin use was associated with a significantly reduced risk of lung cancer among Caucasians and 55- to 64-year-olds. Baby aspirin and NSAID use was associated with a significant reduction in risk of NSCLC only among 65- to 74-year-olds.

Conclusion: Our results suggest that long-term use of adult-strength aspirin may reduce the risk of NSCLC in women. (Cancer Epidemiol Biomarkers Prev 2008;17(1):148–57)

Key Words: Lung cancer, Aspirin, NSAIDs, Women







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2008 by the American Association for Cancer Research.